Biomarkers · Chemical
PA provider. These diagnoses must have evidence of monitoring
- Also listed as
- PA) provider. These diagnoses must have evidence of monitoring
- Tests that measure PA provider. These diagnoses must have evidence of monitoring
- Quest Diagnostics 1
Tests
Check the catalog code, specimen, method and preparation for every test that measures PA provider. These diagnoses must have evidence of monitoring. Select up to five tests to compare them side by side.
Quest Diagnostics 1 test
Panels that include this biomarker
DDX-Risk Comprehensive (Project-CYE) 93407
6 analytes · This Data Diagnostics™ report provides insight into the patient's disease-severity and risk-adjustable diagnoses by identifying which risk adjustment model(s) to which the patient belongs and all known risk-adjustable diagnoses for applicable years as well as risk-adjustable diagnoses that are suspected based on available patient data. The suspected diagnoses are identified through analysis of known pharmacy · Fasting not stated
0 of 5 tests selected
Pick one moreSources
Quest Diagnostics test catalog
1 test: codes, specimens, methods, preparation and reference intervals.
Search ClinicalTrials.gov for PA provider. These diagnoses must have evidence of monitoring
Registered studies that measure PA provider. These diagnoses must have evidence of monitoring, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.